Lewes, DE -- (SBWIRE) -- 10/03/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Paychex, Inc. (NASDAQ:PAYX), Xilinx, Inc. (NASDAQ:XLNX), NXP Semiconductors NV (NASDAQ:NXPI), Myriad Genetics, Inc. (NASDAQ:MYGN).
Paychex, Inc. (NASDAQ:PAYX), decreased -0.10% and closed at $39.94 on a traded volume of 2.21 million shares, in comparison to 1.58 million shares of average trading volume. So far this year, the stock is up over 28.42%.
The company has a total market capitalization of $14.59million and its total outstanding shares are 365.20 million.
Has PAYX Found The Bottom and Ready To Move Up? Find Out Here
Paychex, Inc., together with its subsidiaries, provides payroll, human resource, insurance, and benefits outsourcing solutions for small to medium-sized businesses in the United States and Germany.
Xilinx, Inc. (NASDAQ:XLNX), plunged -1.16% and closed at $46.71 on a traded volume of 2.18 million shares, whereas its average trading volume is 2.64 million shares. In the last three months, the stock is up17.81%. The Intra-day range for the stock is $46.46 and $47.05.
Will XLNX Get Buyers Even After The Recent Rally? Find Out Here
Xilinx, Inc. designs and develops programmable devices and associated technologies worldwide. The company’s programmable devices comprise integrated circuits (ICs) in the form of programmable logic devices (PLDs), such as programmable System on Chips, and three dimensional ICs; software design tools to program the PLDs; targeted reference designs; printed circuit boards; and intellectual property (IP), which consists of Xilinx and various third-party verification and IP cores.
NXP Semiconductors NV (NASDAQ:NXPI), dropped down -0.16% and closed at $37.82. So far in three months, the stock is up 20.64%. The 52-week range for the stock is $20.57 and $39.46 and during the previous trading session it marked$38.01 as its highest price. The stock initially exchanged hands with a price of $37.61 and the overall traded volume that day was 2.15 million shares.
Has NXPI Found The Bottom And Ready To Gain Momentum? Find Out Here
NXP Semiconductors N.V. provides mixed signal and standard product solutions for radio frequency (RF), analog, power management, interface, security, and digital processing products worldwide.
Myriad Genetics, Inc. (NASDAQ:MYGN) after opening its shares at the price of $25.37, dropped -2.17% to close the day at $24.76. The stock ended on a traded volume of 2.15 million shares, in comparison to 2.23 million shares of average trading volume. The 52-week range for the stock is $22.61 and $38.27 and during the previous trading session the stock scored the highest price of $25.49. It started the day at $5.37.
Will MYGN Get Buyers Even After The Recent Rally? Find Out Here
Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests.
About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/